A
ALX Oncology Holdings Inc.
ALXO · NASDAQ · Healthcare · 264M
Price · close
$2.04
+2.51% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
4.2×
Enterprise value / EBITDAEV/EBITDA
-1.0×
Free cash flow yieldFCF yield
-77.1%
Return on equityROE
-391.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
-64.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.